These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1001284)

  • 21. A clinical evaluation of mesantoin in epilepsy.
    MALLIN AW; GAMMON GD
    J Nerv Ment Dis; 1953 Sep; 118(3):193-203. PubMed ID: 13118364
    [No Abstract]   [Full Text] [Related]  

  • 22. Fatal pancytopenia following the use of mesantoin; report of a case.
    WELLER RW; METCALFE J
    N Engl J Med; 1949 Jul; 241(1):17. PubMed ID: 18135085
    [No Abstract]   [Full Text] [Related]  

  • 23. Relation of in vivo drug metabolism to stereoselective fetal hydantoin toxicology in mouse: evaluation of mephenytoin and its metabolite, nirvanol.
    Wells PG; Küpfer A; Lawson JA; Harbison RD
    J Pharmacol Exp Ther; 1982 Apr; 221(1):228-34. PubMed ID: 7062285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aplastic anaemia due to 3-methyl-5-phenyl-5-ethyl-hydantoin ("mesantoin").
    WILLIAMS CM
    Clin Rep; 1960; 10():69-71. PubMed ID: 13785405
    [No Abstract]   [Full Text] [Related]  

  • 25. Mesantoin in the treatment of convulsive disorders.
    LITTLJOHN WS; LITTLE SC; McLALLEN CD
    Dis Nerv Syst; 1951 Sep; 12(9):269-73. PubMed ID: 14887566
    [No Abstract]   [Full Text] [Related]  

  • 26. Mesantoin in the control of epilepsy.
    LOSCALZO AE
    Neurology; 1952; 2(5):403-11. PubMed ID: 14957213
    [No Abstract]   [Full Text] [Related]  

  • 27. Mesantoin in the treatment of epilepsy.
    WISE RA; HEUMANN WA
    Psychiatr Q; 1955 Jul; 29(3):403-11. PubMed ID: 13266919
    [No Abstract]   [Full Text] [Related]  

  • 28. [The Mesantoin in epilepsy].
    PRADO-HUANTE H
    Medicina (Mex); 1956 May; 36(748):229-32. PubMed ID: 13347596
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of epilepsy with mesantoin].
    HALLEN O
    Munch Med Wochenschr; 1953 Aug; 95(35):963-5; concl. PubMed ID: 13087132
    [No Abstract]   [Full Text] [Related]  

  • 30. [The treatment of epilepsy with mesantoin].
    HALLEN O
    Munch Med Wochenschr; 1953 Aug; 95(34):913-4. PubMed ID: 13087111
    [No Abstract]   [Full Text] [Related]  

  • 31. [Results of mesantoin therapy of epilepsy].
    KLOPP HW
    Med Monatsschr; 1951 Nov; 5(11):779-82. PubMed ID: 14910242
    [No Abstract]   [Full Text] [Related]  

  • 32. The metabolic conversion of 3-methyl-5-ethyl-5-phenyl hydantoin (mesantoin) and of 5-ethyl-5-phenyl hydantoin (nirvanol) to 5 - ethyl -5- (p-hydroxyphenyl) hydantoin.
    BUTLER TC
    J Pharmacol Exp Ther; 1956 Jun; 117(2):160-5. PubMed ID: 13332557
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experiences with hydantal Sandoz and Mesantoin in the therapy of epilepsy of children].
    SCHMUTTERMEIER E; STACHEL I
    Osterr Z Kinderheilkd Kinderfuersorge; 1952 Jan; 7(1-2):133-47. PubMed ID: 14948161
    [No Abstract]   [Full Text] [Related]  

  • 34. Evidence for the epoxide-diol pathway in the biotransformation of mephenytoin.
    Gerber N; Thompson RM; Smith RG; Lynn RK
    Epilepsia; 1979 Jun; 20(3):287-94. PubMed ID: 446437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current drug therapy--antiepilepsy agents.
    Am J Hosp Pharm; 1974 Dec; 31(12):1170-8. PubMed ID: 4218450
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased systemic availability of drugs during acute ethanol intoxication: studies with mephenytoin in the dog.
    Zysset T; Preisig R; Bircher J
    J Pharmacol Exp Ther; 1980 Apr; 213(1):173-8. PubMed ID: 7188964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New antiepileptic; 3-methyl-5,5-phenylethyl-hydantoin. (mesantoin Sandoz)].
    SCHERGNA E
    Rass Int Clin Ter; 1951 Feb; 31(4):101-10. PubMed ID: 14844726
    [No Abstract]   [Full Text] [Related]  

  • 38. Changes in the electroencephalogram following administration o mesantoin (methyl-phenyl-ethyl hydantoin).
    LITTLE SC; McAVOY M
    Electroencephalogr Clin Neurophysiol; 1949 Aug; 1(3):325-32. PubMed ID: 18135424
    [No Abstract]   [Full Text] [Related]  

  • 39. [Changes in reactivity to halothane after administration of mephenytoin].
    Pazdera J; Hradecký J; Cvejn J; Zich V
    Vet Med (Praha); 1983; 28(5):269-72. PubMed ID: 6410574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatal granulocytopenia following hydantoins, mesantoin and dilantin; report of a case.
    BERNHARDT H
    J Med Assoc State Ala; 1950 Jan; 19(7):193-7. PubMed ID: 15408514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.